Dr. Reddy's Laboratories
RDY
#1816
Rank
S$14.29 B
Marketcap
S$17.12
Share price
-1.11%
Change (1 day)
-2.48%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): S$1.13 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are S$3.95 Billion. a decrease over its 2024 earnings that were of S$1.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 S$1.12 B-2.73%
2024 S$1.15 B7.01%
2023 S$1.07 B17.62%
2022 S$0.91 B43.27%
2021 S$0.64 B31.44%
2020 S$0.48 B54.54%
2019 S$0.31 B-12.26%
2018 S$0.35 B23.6%
2017 S$0.29 B4.47%
2016 S$0.27 B-55.7%
2015 S$0.62 B1.83%
2014 S$0.61 B-3.78%
2013 S$0.64 B54.07%
2012 S$0.41 B-16.23%
2011 S$0.49 B56.66%
2010 S$0.31 B-235.36%
2009 -S$0.24 Billion-198.53%
2008 S$0.23 B30.77%
2007 S$0.18 B-14.61%
2006 S$0.21 B703.63%
2005 S$26.47 M649.45%
2004 S$3.53 M-95.68%
2003 S$81.7 M-14.86%
2002 S$95.96 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$21.02 B 1,772.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.10 B 1,066.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.89 B 781.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
S$12.72 B 1,033.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$2.76 B 146.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel